Skip to main content
Clinical Trials/NCT05737056
NCT05737056
Completed
Not Applicable

Rheumatoid Purpura in Children: a Multicenter Observational Study of Pediatric Emergency Department Management and Follow-up by Primary Care Physicians

Groupe Hospitalier de la Region de Mulhouse et Sud Alsace2 sites in 1 country66 target enrollmentMay 9, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rheumatoid Purpura
Sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Enrollment
66
Locations
2
Primary Endpoint
Compliance with the recommendations for the management of rheumatoid purpura
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

The main objective of this study is to describe the management of children with rheumatoid purpura from admission to the pediatric emergency room to follow-up by primary care physicians after hospital discharge.

Detailed Description

Secondary objectives The secondary objective is to assess general practitioners current knowledge and practice of the condition and potential barriers to monitoring and follow-up by general practitioners. Conduct of research Children diagnosed with rheumatoid purpura within the past 2 years at the 3 participating sites will be included in the study if parental authority holders do not object. Patients will be identified through the Medical Information Department of each hospital. Parents will be contacted - first by mail, then by phone - to request permission to collect the child's medical data from medical records, and to retrieve information on the surveillance and follow-up of the disease by general practitioners up to two years after diagnosis.

Registry
clinicaltrials.gov
Start Date
May 9, 2023
End Date
July 28, 2023
Last Updated
5 months ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Underaged patient diagnosed with rheumatoid purpura during a visit to the pediatric emergencies of Mulhouse, Colmar and Strasbourg
  • No objection to the study from the two holders of parental authority

Exclusion Criteria

  • \- Patient followed in the context of a genetic or malformative pathology, an immune deficiency, or a cancer

Outcomes

Primary Outcomes

Compliance with the recommendations for the management of rheumatoid purpura

Time Frame: Up to two years after hospital discharge

Secondary Outcomes

  • Knowledge assessment questionnaire regarding rheumatoid purpura(At the beginning of the study)

Study Sites (2)

Loading locations...

Similar Trials